What is Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Annual Revenue?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Annual Revenue rose 16.73%, in the last year to $2,793.96 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Annual Net Profit?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Annual Net Profit fell 39.16% in the last year to $116.89 M. Its sector's average net profit growth for the last fiscal year was -11.16%.

What is Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Price to Earning Ratio?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Price to Earning Ratio is -174.15, which is negative.

What is Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Quarterly Revenue?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Quarterly Revenue rose 5.5% YoY to $695.42 M. Its sector's average revenue growth YoY for the quarter was 3.13%.

What is Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Quarterly Net profit?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Quarterly Net profit rose 113.31% YoY to $12.2 M. Its sector's average net profit growth YoY for the quarter was -200.49%.

What is Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Mutual Fund Holding?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Mutual Fund Holding increased by 0.53% in the last quarter to 22.67.

What is Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Promoter Share Holding?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Promoter Share Holding increased by 0.53% in the most recent quarter to 4.85%.

What is Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Interest Coverage Ratio?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Interest Coverage Ratio is 0.79, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Institutional Holding?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Institutional Holding increased by 1.4% in the last quarter to 41.05.

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A XNAS: AMRX

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Amneal Pharmaceuticals Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
Rating: 1.67566675
Author: Trendlyne DVM scores

about

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essentia...

7.25 -0.17 (-2.29%)

717.8K XNAS Volume

XNAS 21 May, 2025 2:04 PM (EDT)

Not Eligible

-

Expensive Valuation

26.7 / 100

Technically Neutral

40.4 / 100

12

1Yr Price target upside is 61%

3 analysts

Amneal Pharmaceuticals Inc... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A FAQ

How is Amneal Pharmaceuticals Inc - Ordinary Shares - Class A today?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A today is trading in the red, and is down by -2.29% at 7.25.

How has Amneal Pharmaceuticals Inc - Ordinary Shares - Class A performed historically?

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A is currently trading down -2.29% on an intraday basis. In the past week the stock fell -3.33%. stock has been down -7.88% in the past quarter and rose 7.73% in the past year. You can view this in the overview section.